Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans

Clinical Endocrinology

Volumn 60, Issue 6, 2004, Pages 699-704

  Broglio, Fabio ^a,b   Prodam, Flavia ^b   Gottero, Cristina ^b   Destefanis, Silvia ^b   Me, Elisa ^b   Riganti, Fabrizio ^b   Giordano, Roberta ^b   Picu, Andreea ^b   Balbo, Marcella ^b   Van Der Lely, Aart Jan ^a   Ghigo, Ezio ^b   Arvat, Emanuela ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GHRELIN; GLUCAGON; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; SODIUM CHLORIDE;

ADULT; ARTICLE; BODY MASS; CIRCULATION; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG EFFECT; DRUG RESPONSE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; INFUSION; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; STIMULATION;

ADRENOCORTICOTROPIC HORMONE; ADULT; BLOOD GLUCOSE; GLUCAGON; GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; MALE; PEPTIDE HORMONES; PITUITARY-ADRENAL SYSTEM;

EID: 2942722385     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.02038.x     Document Type: Article

References (46)

1. Arvat, E., Maccario, M., Di Vito, L., Broglio, F., Benso, A., Gottero, C., Papotti, M., Muccioli, G., Dieguez, C., Casanueva, F.F., Deghenghi, R., Camanni, F. & Ghigo, E. (2001) Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. Journal of Clinical Endocrinology and Metabolism, 86, 1169-1174.
2. Asnicar, M.A., Sun, Y. & Smith, R.G. (2003) Ghrelin deficiency does not protect against diet induced obesity in mice. In: 85th Annual Meeting of the Endocrine Society, Philadelphia, Pennsylvania, Abstract P1-215.
3. Barkan, A.L., Dimaraki, E.V., Jessup, S.K., Symons, K.V., Ermolenko, M. & Jaffe, C.A. (2003) Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. Journal of Clinical Endocrinology and Metabolism, 88, 2180-2184.
4. Broglio, F., Arvat, E., Benso, A., Gottero, C., Prodam, F., Grottoli, S., Papotti, M., Muccioli, G., van der Lely, A.J., Deghenghi, R. & Ghigo, E. (2002a) Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans. Journal of Clinical Endocrinology and Metabolism, 87, 3783-3790.
5. Broglio, F., Benso, A., Gottero, C., Prodam, F., Grottoli, S., Tassone, F., Maccario, M., Casanueva, F.F., Dieguez, C., Deghenghi, R., Ghigo, E. & Arvat, E. (2002b) Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clinical Endocrinology, 57, 265-271.
6. Broglio, F., Koetsveld, Pv. P., Benso, A., Gottero, C., Prodam, F., Papotti, M., Muccioli, G., Gauna, C., Hofland, L., Deghenghi, R., Arvat, E., van der Lely, A.J. & Ghigo, E. (2002c) Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. Journal of Clinical Endocrinology and Metabolism, 87, 4829-4832.
7. Broglio, F., Arvat, E., Gottero, C., Benso, A., Prodam, F., Destefanis, S., Aimaretti, G., Papotti, M., Muccioli, G., Deghenghi, R. & Ghigo, E. (2003b) Natural and synthetic growth hormone secretagogues. Do they have therapeutical potential? Treatments in Endocrinology, 2, 153-163.
8. Broglio, F., Benso, A., Gottero, C., Prodam, F., Gauna, C., Filtri, L., Arvat, E., van der Lely, A.J., Deghenghi, R. & Ghigo, E. (2003a) Non-acylated-ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin. Journal of Endocrinological Investigation, 26, 192-196.
9. Caixas, A., Bashore, C., Nash, W., Pi-Sunyer, F. & Laferrere, B. (2002) Insulin, unlike food intake, does not suppress ghrelin in human subjects. Journal of Clinical Endocrinology and Metabolism, 87, 1902-1906.
10. Chapman, I.M., Bach, M.A., Van Cauter, E., Farmer, M., Krupa, D., Taylor, A.M., Schilling, L.M., Cole, K.Y., Skiles, E.H., Pezzoli, S.S., Hartman, M.L., Veldhuis, J.D., Gormley, G.J. & Thorner, M.O. (1996) Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. Journal of Clinical Endocrinology and Metabolism, 81, 4249-4257.
11. Copinschi, G., Van Onderbergen, A., L'Hermite-Baleriaux, M., Mendel, C.M., Caufriez, A., Leproult, R., Bolognese, J.A., De Smet, M., Thorner, M.O. & Van Cauter, E. (1996) Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. Journal of Clinical Endocrinology and Metabolism, 81, 2776-2782.
12. Date, Y., Nakazato, M., Hashiguchi, S., Dezaki, K., Mondal, M.S., Hosoda, H., Kojima, M., Kangawa, K., Arima, T., Matsuo, H., Yada, T. & Matsukura, S. (2002) Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes, 51, 124-129.
13. Di Vito, L., Broglio, F., Benso, A., Gottero, C., Prodam, F., Papotti, M., Muccioli, G., Dieguez, C., Casanueva, F.F., Deghenghi, R., Ghigo, E. & Arvat, E. (2002) The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Clinical Endocrinology, 56, 643-648.
14. Flanagan, D.E., Evans, M.L., Monsod, T.P., Rife, F., Heptulla, R.A., Tamborlane, W.V. & Sherwin, R.S. (2003) The influence of insulin on circulating ghrelin. American Journal of Physiology - Endocrinology and Metabolism, 284, E313-E316.
15. Ghigo, E., Bartolotta, E., Imperiale, E., Bellone, J., Cardinale, G., Aimaretti, G., Valette, M.R., Cherubini, V., Maccario, M. & Cocchi, D. (1994) Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity. Journal of Endocrinological Investigation, 17, 849-854.
16. Ghigo, E., Arvat, E., Gianotti, L., Grottoli, S., Rizzi, G., Ceda, G.P., Boghen, M.F., Deghenghi, R. & Camanni, F. (1996) Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone responsiveness in human aging. European Journal of Endocrinology, 135, 407-412.
17. Ghigo, E., Arvat, E., Ramunni, J., Colao, A., Gianotti, L., Deghenghi, R., Lombardi, G. & Camanni, F. (1997) Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 82, 2439-2444.
18. Gnanapavan, S., Kola, B., Bustin, S.A., Morris, D.G., McGee, P., Fairclough, P., Bhattacharya, S., Carpenter, R., Grossman, A.B. & Korbonits, M. (2002) The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. Journal of Clinical Endocrinology and Metabolism, 87, 2988-2992.
19. Hataya, Y., Akamizu, T., Takaya, K., Kanamoto, N., Ariyasu, H., Saijo, M., Moriyama, K., Shimatsu, A., Kojima, M., Kangawa, K. & Nakao, K. (2001) A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. Journal of Clinical Endocrinology and Metabolism, 86, 4552-4556.
20. Kishimoto, M., Okimura, Y., Nakata, H., Kudo, T., Iguchi, G., Takahashi, Y., Kaji, H. & Chihara, K. (2003) Cloning and characterization of the 5(')-flanking region of the human ghrelin gene. Biochemical and Biophysical Research Communications, 305, 186-192.
21. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H. & Kangawa, K. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656-660.
22. Kojima, M., Hosoda, H. & Kangawa, K. (2001) Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor. Hormone Research, 56, 93-97.
23. Korbonits, M., Bustin, S.A., Kojima, M., Jordan, S., Adams, E.F., Lowe, D.G., Kangawa, K. & Grossman, A.B. (2001) The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. Journal of Clinical Endocrinology and Metabolism, 86, 881-887.
24. Kuschke, H.J., Klusmann, H. & Scholkens, B. (1966) Studies on the effect of glucagon on the human sympatho-adrenal system. Klinische Wochenschrift, 44, 1297-1300.
25. Leal-Cerro, A., Torres, E., Soto, A., Dios, E., Deghenghi, R., Arvat, E., Ghigo, E., Dieguez, C. & Casanueva, F.F. (2002) Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses. Neuroendocrinology, 76, 390-396.
26. Leong, K.S., Walker, A.B., Martin, I., Wile, D., Wilding, J. & MacFarlane, A. (2001) An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic- pituitary disease. Clinical Endocrinology, 54, 463-468.
27. Lucidi, P., Murdolo, G., Di Loreto, C., De Cicco, A., Parlanti, N., Fanelli, C., Santeusanio, F., Bolli, G.B. & De Feo, P. (2002) Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycaemia. Diabetes, 51, 2911-2914.
28. Massoud, A.F., Hindmarsh, P.C. & Brook, C.G. (1996) Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study. Journal of Clinical Endocrinology and Metabolism, 81, 4338-4341.
29. Melmed, S. & Kleinberg, D. (2003) Anterior Pituitary. In: Williams Textbook of Endocrinology, 10th edn, (eds P. R. Larsen, H. M. Kronenberg, S. Melmed & K. S. Polonsky), pp. 177-280. Elsevier Science, Philadelphia.
30. Mohlig, M., Spranger, J., Otto, B., Ristow, M., Tschop, M. & Pfeiffer, A.F. (2002) Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. Journal of Endocrinological Investigation, 25, RC36-RC38.
31. Muccioli, G., Tschop, M., Papotti, M., Deghenghi, R., Heiman, M. & Ghigo, E. (2002) Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. European Journal of Pharmacology, 440, 235-254.
32. Muller, A.F., Lamberts, S.W., Janssen, J.A., Hofland, L.J., Koetsveld, P.V., Bidlingmaier, M., Strasburger, C.J., Ghigo, E. & Van der Lely, A.J. (2002) Ghrelin drives GH secretion during fasting in man. European Journal of Endocrinology, 146, 203-207.
33. Norrelund, H., Hansen, T.K., Orskov, H., Hosoda, H., Kojima, M., Kangawa, K., Weeke, J., Moller, N., Christiansen, J. S. & Jorgensen, J.O. (2002) Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clinical Endocrinology, 57, 539-546.
34. Popovic, V., Miljic, D., Micic, D., Damjanovic, S., Arvat, E., Ghigo, E., Dieguez, C. & Casanueva, F.F. (2003) Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. Journal of Clinical Endocrinology and Metabolism, 88, 3450-3453.
35. Rao, R.H. & Spathis, G.S. (1987) Intramuscular glucagon as a provocative stimulus for the assessment of pituitary function: growth hormone and cortisol responses. Metabolism, 36, 658-663.
36. Saad, M.F., Bernaba, B., Hwu, C.M., Jinagouda, S., Fahmi, S., Kogosov, E. & Boyadjian, R. (2002) Insulin regulates plasma ghrelin concentration. Journal of Clinical Endocrinology and Metabolism, 87, 3997-4000.
37. Schaller, G., Schmidt, A., Pleiner, J., Woloszczuk, W., Wolzt, M. & Luger, A. (2003) Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes, 52, 16-20.
38. Seoane, L.M., Lopez, M., Tovar, S., Casanueva, F.F., Senaris, R. & Dieguez, C. (2003) Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology, 144, 544-551.
39. Shiiya, T., Nakazato, M., Mizuta, M., Date, Y., Mondal, M.S., Tanaka, M., Nozoe, S., Hosoda, H., Kangawa, K. & Matsukura, S. (2002) Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. Journal of Clinical Endocrinology and Metabolism, 87, 240-244.
40. Smith, R.G., Van der Ploeg, L.H., Howard, A.D., Feighner, S.D., Cheng, K., Hickey, G.J., Wyvratt, M.J. Jr, Fisher, M.H., Nargund, R.P. & Patchett, A.A. (1997) Peptidomimetic regulation of growth hormone secretion. Endocrine Review, 18, 621-645.
41. Tannenbaum, G.S., Epelbaum, J. & Bowers, C.Y. (2003) Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology, 144, 967-974.
42. Tolle, V., Bassant, M.H., Zizzari, P., Poindessous-Jazat, F., Tomasetto, C., Epelbaum, J. & Bluet-Pajot, M.T. (2002) Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology, 143, 1353-1361.
43. Ukkola, O. (2003) Ghrelin and insulin metabolism. European Journal of Clinical Investigation, 33, 183-185.
44. Volante, M., Allia, E., Gugliotta, P., Funaro, A., Broglio, F., Deghenghi, R., Muccioli, G., Ghigo, E. & Papotti, M. (2002) Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. Journal of Clinical Endocrinology and Metabolism, 87, 1300-1308.
45. Wierup, N., Svensson, H., Mulder, H. & Sundler, F. (2002) The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regulation Peptide, 107, 63-69.
46. Wren, A.M., Small, C.J., Fribbens, C.V., Neary, N.M., Ward, H.L., Seal, L.J., Ghatei, M.A. & Bloom, S.R. (2002) The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology, 76, 316-324.